<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03981601</url>
  </required_header>
  <id_info>
    <org_study_id>2038</org_study_id>
    <nct_id>NCT03981601</nct_id>
  </id_info>
  <brief_title>Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Lovastatin in the Preservation of the Tooth Socket</brief_title>
  <official_title>the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) With Lovastatin in the Preservation of the Tooth Socket</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamic Azad University, Tehran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamic Azad University, Tehran</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Twenty patients referring to periodontics department of Boroujerd Azad university of
      dentistry after obtaining consent to participate in the research project, which have more
      than 20 teeth, are over 18 years old and require socket preservation surgery to tooth
      extraction for the periodontal problem, caries or Fractures were selected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      twenty healthy patients referring to periodontics department of Boroujerd Azad university of
      dentistry after obtaining consent to participate in the research project, which has more than
      20 teeth, are over 18 years old and require socket preservation surgery to tooth extraction
      for the periodontal problem, caries or Fractures were selected. moreover, divided the socket
      randomly to two groups(A, B)including A: bone graft with lovastatin and B: bone graft alone,
      after 3 months with trephine will collect the samples. following the histomorphometric
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2018</start_date>
  <completion_date type="Anticipated">July 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 30, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Socket preservation with Lovastatin as evaluated by the amount of bone formation volume</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Bone Loss</condition>
  <arm_group>
    <arm_group_label>lovastatin 40 mg with bone graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after tooth extraction, put teh lovastatin40 mg wif bone graft wifin tooth socket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without drug with bone graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after tooth extraction, put the bone graft wifin tooth socket</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lovastatin 40 MG</intervention_name>
    <description>after tooth extraction, put teh lovastatin40 mg wif bone graft wifin tooth socket</description>
    <arm_group_label>lovastatin 40 mg with bone graft</arm_group_label>
    <other_name>Group A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>without drug with Bone graft</intervention_name>
    <description>after tooth extraction, put teh bone graft wifin tooth socket</description>
    <arm_group_label>without drug with bone graft</arm_group_label>
    <other_name>Group B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. at least 18 years old

          2. tooth fracture, root caries

          3. Patients are volunteered for placement of the implant

        Exclusion Criteria:

          1. systemic diseases

          2. Pregnancy and breastfeeding

          3. malignancy, radiation therapy,

          4. history of periodontal surgery during the six months ago.

          5. medicine(phosphonates, antibiotic,...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amirhossein Farahmand, Assistant Prof</last_name>
    <phone>+98 912 404 0359</phone>
    <email>perio-implant@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amirhossein Farahmand</name>
      <address>
        <city>Tehran</city>
        <zip>19</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amirhossein Farahmand, Assistant Prof</last_name>
      <phone>+98 912 4040 359</phone>
      <email>perio-implant@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>February 9, 2019</study_first_submitted>
  <study_first_submitted_qc>June 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2019</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamic Azad University, Tehran</investigator_affiliation>
    <investigator_full_name>Amirhossein Farahmand</investigator_full_name>
    <investigator_title>assistant prof</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lovastatin</mesh_term>
    <mesh_term>L 647318</mesh_term>
    <mesh_term>Dihydromevinolin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

